The aim of the 4-yr Combination of Avodart and Tamsulosin (CombAT) study is to investigate whether combinationtherapy with the alpha-blocker tamsulosin and the dual 5-ARI dutasteride is more effective thaneithermonotherapy alone for improvement of symptoms and for long-term clinical outcomes of acute urinary retention (AUR) and BPH-related prostatic surgery in men with moderate- to-severe symptoms of BPH and prostatic enlargement
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study
MIRONE, VINCENZO;
2009-01-01
Abstract
The aim of the 4-yr Combination of Avodart and Tamsulosin (CombAT) study is to investigate whether combinationtherapy with the alpha-blocker tamsulosin and the dual 5-ARI dutasteride is more effective thaneithermonotherapy alone for improvement of symptoms and for long-term clinical outcomes of acute urinary retention (AUR) and BPH-related prostatic surgery in men with moderate- to-severe symptoms of BPH and prostatic enlargementFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
